Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2020 | The imSAVAR project: making immunomodulatory therapies safer

Ulrike Koehl • 30 Jan 2020
CAR-T Meeting 2020
General CAR-T

Ulrike Koehl, MD, PhD, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany, discusses the imSAVAR project which aims to deliver a range of tools to improve the ability to assess the efficacy and safety of immunomodulatory therapies. Another aim is to develop new biomarkers for diagnosing and predicting immune-mediated safety issues and explore ways of mitigating them. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.

More from Ulrike Koehl

0:46
Scaling up CAR-T manufacturing with automation and digitalization
Ulrike Koehl • 7 Feb 2022
0:56
Minimizing the costs of CAR-T manufacturing
Ulrike Koehl • 7 Feb 2022
0:49
Centralized vs decentralized manufacturing of CAR-T therapies
Ulrike Koehl • 7 Feb 2022
0:44
NK cells vs T-cells
Ulrike Koehl • 7 Feb 2022

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals